v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Cash flows from operating activities:    
Net loss $ (70,135) $ (82,055)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 6,966 5,877
Depreciation and amortization 20,836 18,151
Non-cash interest expense on finance obligations 1,188 1,081
Unrealized (gain) loss on derivative contracts (301) 5,020
Operating lease costs 673 703
Operating lease payments (682) (700)
Other, net 160 11
Decrease (increase) in operating assets:    
Accounts receivable 1,718 (3,346)
Unbilled receivables (13,736) (5,728)
Inventories (11,986) (29,462)
Other assets (6,353) (2,303)
(Decrease) increase in operating liabilities:    
Accounts payable 954 (6,259)
Accrued liabilities (4,782) (985)
Deferred revenue (115) 4,605
Net cash used in operating activities (75,595) (95,390)
Cash flows from investing activities:    
Capital expenditures (12,341) (23,773)
Project asset expenditures (222) (8,201)
Maturity of held-to-maturity debt securities 711,445 260,855
Purchases of held-to-maturity debt securities (660,969) (256,285)
Net cash provided by (used in) investing activities 37,913 (27,404)
Cash flows from financing activities:    
Repayment of debt and finance obligations (6,342) (5,248)
Proceeds from the issuance of debt   13,000
Payment for deferred financing costs (115) (372)
Common stock issued for stock plans and related expenses 16 68
Contributions received from sale of noncontrolling interest, net of return of capital 4,000 25,122
Distribution to noncontrolling interest (1,165) (661)
Payments for taxes related to net share settlement of equity awards (490) (1,045)
Common stock issuance, net of fees 13,557 5,892
Payment of preferred dividends (1,600) (1,600)
Net cash provided by financing activities 7,861 35,156
Effects on cash from changes in foreign currency rates 54 (45)
Net decrease in cash, cash equivalents and restricted cash (29,767) (87,683)
Cash, cash equivalents and restricted cash-beginning of period 208,883 299,576
Cash, cash equivalents and restricted cash-end of period $ 179,116 $ 211,893